Cefoxitin Sodium

Producers shown on SFDA

(Record date:03/09/2021）

Producers shown on EP

(Quoted from EP website；record date:03/09/2021）

Producer:Shenzhen Salubris Pharmaceuticals Co., Ltd., established in 1998 and listed on Shenzhen Stock Exchange in 2009, is a comprehensive pharmaceutical listed company integrating pharmaceutical product R & D, production and sales. The company accurately distributes the global industrial chain, covering more than 30 countries and regions such as China, the United States, Germany, France and Japan. All products and production workshops of the company have passed the domestic GMP certification, Daya Bay production base has passed the EU GMP certification, and the key product Taijia has obtained the listing license of 12 EU countries. All kinds of products enjoy a good reputation in the industry.
Staff size:About 3500 persons

Registered capital:RMB 1 billion 115 million

Producer:Chongqing Tiandi Pharmaceutical Co., Ltd., established in December 2003, is a holding subsidiary of the listed company Hainan sea Co., Ltd., with total assets of 230 million yuan. All products have passed GMP certification of the State Food and Drug Administration and ISO9001 certification of China Quality Certification Center. After 8 years of continuous development, the company has established a strategic partnership for sustainable development with many well-known pharmaceutical enterprises in China.

Staff size:500-599 persons

Registered capital:RMB 532 million 916 thousand and 370

Producer:Sinopharm Zhijun (Suzhou) Pharmaceutical Co., Ltd. is subordinate to Shanghai Modern Pharmaceutical Co., Ltd., a chemical pharmaceutical platform of China Pharmaceutical Group. It is a leading enterprise in Sinopharm's anti infection sector. The company has passed the EU certification of cephalosporin powder injection, cephalosporin solid preparation, who PQ certification and other international high standard certification. It is a supplier of ceftriaxone certified by who PQ in China. The company's key product dalixin tablet is the first batch of cephalosporin antibiotics that have passed the consistency evaluation in China.

Staff size:About 50 persons

Registered capital:RMB 180 million

Producer:Zhejiang Dongying Pharmaceutical Co., Ltd. was established in 2005 and was wholly acquired by Zhejiang Guobang Pharmaceutical Co., Ltd. in March 2013. All products of the company have passed the national pharmaceutical GMP certification and are committed to the R & D, production and operation of cephalosporin antibiotics. It has an annual production capacity of 150 tons of cephalosporin sterile API, 600 tons of oral cephalosporin API and 1000 tons of pharmaceutical intermediates.

Staff size:100-199 persons

Registered capital:RMB 234 million 57 thousand and 776

Producer:Established in 2001, Guangdong Bozhou Pharmaceutical Co., Ltd. has three preparation production lines with an annual output of 30 million powder injections, 500 million tablets and 200 million capsules, as well as API production lines such as Cefpiramide, cefterem pivoxil, Cefminox Sodium, ceftizol sodium, cefnica sodium, cefathiamidine, cefpirome thioate and cefoxitin sodium, all of which have passed the national GMP certification, It covers an area of 50000 square meters.

Staff size:50-99 persons
Registered capital:RMB 20 million

Producer:Suzhou Shengda Pharmaceutical Co., Ltd.（formerly China Union Chempharma(suzhou) Co., Ltd.）, founded in 2003, covers an area of more than 66000 square meters. It is a high-tech enterprise specializing in the R & D, production and sales of cephalosporin antibiotics. Product categories include oral API and sterile API. All products have passed the national GMP certification

Staff size:200-299 persons

Registered capital:RMB 10 million

Producer:Shandong Ruiying Pharmaceutical Group Co., Ltd. (formerly Shandong Ruiying Xianfeng Pharmaceutical Co., Ltd.) is a large pharmaceutical manufacturing enterprise integrating scientific research, pilot test, production and sales, covering the fields of biological fermentation, chemical synthesis, aseptic pharmacy and so on, forming a complete industrial chain.

The company has passed the international quality system certification, the GMP certification of the State Food and drug administration, the national EHS certification and the KFDA certification of South Korea, and has its own import and export rights. In addition to sales at home and abroad, its products are also exported to more than a dozen countries such as Europe, America and so on.

Staff size:900-999 persons

Registered capital:RMB 40 million

Producer:Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Luoxin Pharmaceutical Group Co., Ltd.

Luoxin Pharmaceutical Group Co., Ltd. is a large pharmaceutical enterprise group integrating drug R & D, production, trade and medical and health services.At present, This company has four manufacturing bases, including more than 50 production lines, including powder injection, lyophilized powder injection, solid preparation (including cephalosporins), spray, aerosol, pre encapsulation, large capacity injections, small volume injections, chemical raw materials, cephalosporins, and so on. There are more than ten dosage forms and more than 300 product specifications on the market. There are 48 national new drugs. The company can produce 1 billion powder injections, 500 million freeze-dried powder injections, 400 million large bottles of injections (bags), 500 million small volume injections, 7 billion tablets, 2 billion capsules, 300 million capsules, 80 million dry suspensions, 300 tons of micro pills, 1000 tons of raw materials, 30 million aerosol cans, spray ingredients, and pre encapsulated branches.

Staff size:RMB 50 million

Registered capital:700-799 persons

Producer:Zhuhai United Laboratories Co., Ltd. is a subsidiary of The United Laboratories International Holdings Limited (United Lab). United Lab now has 11 major series of preparation products, more than 60 varieties, more than 120 product specifications, and nearly 50 varieties of 5 major series of API and intermediate products. All workshops of UL have passed the new version of GMP certification in China, and many products have successively obtained EU GMP certification and US FDA certification. With advanced enzymatic production technology, UL has become the first enterprise in China to obtain the EU CEP certificate of enzymatic amoxicillin, and a number of scientific and technological achievements have obtained national patents.

United Labowns advanced production equipment and adequate production capacity. Every year, it can produce 1.8 billion capsules, 1 billion tablets, 134 million sachets of granules, 86 million sachets of suspension, 20 million vials of oral solution, 117 million vials of powder injections, 37.8 million tubes of ointments, 28 million vials of lyophilized powder for injection, 24 million tubes of eye drops and about 300 million tubes of insulin preparation.

Staff size:2000-2999 persons

Registered capital:RMB 1 billion 678 million 396 thousand

Producer:NCPC Hebei Huamin Pharmaceutical Co., Ltd.was officially established in April 2010. The company now has two antibiotic mother cores, 7-ACA and 7-ADCA, and 63 drug production numbers including raw materials and preparations. The products cover the leading varieties of cephalosporin generation 1 to 4. It has become the first complete industrial chain of North China pharmaceutical - a professional company for the production and operation of cephalosporin products, It has formed a command platform for the unified production and operation of cephalosporin from raw materials to preparations.

Staff size:1000-1999 persons

Registered capital:RMB 1 billion 450 million 139 thousand

Producer:Guangxi Kelun Pharmaceutical Co., Ltd. (formerly Guilin Dahua), now subordinate to Sichuan Kelun Pharmaceutical Co., Ltd., founded on November 22, 1996, is a manufacturer of cephalosporin antibiotic API and powder injection. The plant covers a total area of 79847.29 square meters, including a construction area of 14599.49 square meters. Guangxi Kelun became the first batch of GMP compliant units in 1999. At present, the factory is the only production base of cephalosporin antibiotics in Guangxi, which is fully equipped from API to preparation.
Staff size:400-499 persons

Registered capital:RMB 60 million